ILLUMINA COVIDSEQ
Illumina, Inc.
Application Filed: 2020-04-29
Trademark Application Details
STATEMENT OF USE - TO EXAMINER
| Research |
OneLook
Acronym Finder
|
| Serial Number | 88983897 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
| Attorney Name | Susan M. Natland |
| Attorney Docket Number | ILLINCT.691T |
| Law Office Assigned | M90 |
| Employee Name | HUSSAIN, TASNEEM |
Timeline
| 2020-04-29 | Application Filed |
| 2021-06-08 | Published for Opposition |
| 2022-03-03 | Location: TMO LAW OFFICE 118 |
| 2022-03-03 | Status: Live/Pending |
| 2022-03-03 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  Illumina, Inc. |
| Address | 5200 Illumina Way San Diego DE 92122 |
| Legal Entity Type | Corporation |
| Legal Entity State | DE |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 1 |
| U.S. Codes: | 001,005,006,010,026,046 |
| International Codes: | 5 |
| U.S. Codes: | 005,006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| GS0051 | Agents, reagents, assays, enzymes, nucleotides, buffers, chemical preparations, and biological preparations for scientific and research use; Diagnostic reagents and preparations, other than for medical or veterinary use; Kits comprised principally of reagents with a protocol for use thereof for non-medical purposes; Agents, reagents, assays, enzymes, nucleotides, buffers, chemical preparations, and biological preparations for scientific and research use in the fields of nucleic acid sequencing, genotyping, diagnostics, diagnostic research, clinical research, drug development, pharmaceuticals, laboratory research, scientific research, medical research, life sciences, biology, microbiology and metagenomics, biotechnology, genetic testing, and genetics, not for medical or veterinary purposes; Kits comprising nucleotides, reagents, enzymes, agents, assays, buffers, chemical preparations, and biological preparations for scientific and research use including in the fields of nucleic acid sequencing, genotyping, diagnostics, diagnostic research, clinical research, drug development, pharmaceuticals, laboratory research, scientific research, medical research, life sciences, biology, microbiology and metagenomics, biotechnology, genetic testing, and genetics, not for medical or veterinary purposes; all of the foregoing for the detection of or in the field of COVID-19 |
| GS0051 | Agents, reagents, assays, enzymes, nucleotides, buffers, chemical preparations, and biological preparations for scientific and research use; Diagnostic reagents and preparations, other than for medical or veterinary use; Kits comprised principally of reagents with a protocol for use thereof for non-medical purposes; Agents, reagents, assays, enzymes, nucleotides, buffers, chemical preparations, and biological preparations for scientific and research use in the fields of nucleic acid sequencing, genotyping, diagnostics, diagnostic research, clinical research, drug development, pharmaceuticals, laboratory research, scientific research, medical research, life sciences, biology, microbiology and metagenomics, biotechnology, genetic testing, and genetics, not for medical or veterinary purposes; Kits comprising nucleotides, reagents, enzymes, agents, assays, buffers, chemical preparations, and biological preparations for scientific and research use including in the fields of nucleic acid sequencing, genotyping, diagnostics, diagnostic research, clinical research, drug development, pharmaceuticals, laboratory research, scientific research, medical research, life sciences, biology, microbiology and metagenomics, biotechnology, genetic testing, and genetics, not for medical or veterinary purposes; all of the foregoing for the detection of or in the field of COVID-19 |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| NEW APPLICATION ENTERED IN TRAM | 2020-05-02 | 1 NWAP I:Incoming Correspondence |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2020-05-12 | 2 NWOS I:Incoming Correspondence |
| ASSIGNED TO EXAMINER | 2020-10-19 | 3 DOCK D:Assigned to Examiner |
| ASSIGNED TO EXAMINER | 2020-10-19 | 4 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION WRITTEN | 2020-10-21 | 5 CNRT R:Renewal |
| NON-FINAL ACTION E-MAILED | 2020-10-21 | 6 GNRT F:First Action |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2020-10-21 | 7 GNRN O:Outgoing Correspondence |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2021-04-21 | 8 TROA I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2021-04-21 | 9 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2021-04-22 | 10 TEME I:Incoming Correspondence |
| EXAMINERS AMENDMENT -WRITTEN | 2021-04-30 | 11 CNEA R:Renewal |
| EXAMINERS AMENDMENT E-MAILED | 2021-04-30 | 12 GNEA O:Outgoing Correspondence |
| NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | 2021-04-30 | 13 GNEN O:Outgoing Correspondence |
| EXAMINER'S AMENDMENT ENTERED | 2021-04-30 | 14 XAEC I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2021-05-03 | 15 CNSA P: |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2021-05-19 | 16 NONP E:E-Mail |
| PUBLISHED FOR OPPOSITION | 2021-06-08 | 17 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2021-06-08 | 18 NPUB E:E-Mail |
| NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 2021-08-03 | 19 NOAM E:E-Mail |
| TEAS EXTENSION RECEIVED | 2022-02-01 | 20 EEXT I:Incoming Correspondence |
| EXTENSION 1 FILED | 2022-02-01 | 21 EXT1 S: |
| EXTENSION 1 GRANTED | 2022-02-01 | 22 EX1G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2022-02-03 | 23 EXRA E:E-Mail |
| TEAS STATEMENT OF USE RECEIVED | 2022-02-16 | 24 EISU I:Incoming Correspondence |
| TEAS REQUEST TO DIVIDE RECEIVED | 2022-02-16 | 25 ERTD I:Incoming Correspondence |
| CASE ASSIGNED TO INTENT TO USE PARALEGAL | 2022-03-03 | 26 AITU A:Allowance for Publication |
| DIVISIONAL REQUEST RECEIVED | 2022-02-16 | 27 DRRR I:Incoming Correspondence |
| DIVISIONAL PROCESSING COMPLETE | 2022-03-03 | 28 DPCC D:Assigned to Examiner |
| USE AMENDMENT FILED | 2022-02-16 | 29 IUAF S: |
| STATEMENT OF USE PROCESSING COMPLETE | 2022-03-03 | 30 SUPC I:Incoming Correspondence |
| SU - NON-FINAL ACTION - WRITTEN | 2022-03-08 | 31 CNRT W: |
| NON-FINAL ACTION E-MAILED | 2022-03-08 | 32 GNRT O:Outgoing Correspondence |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2022-03-08 | 33 GNRN O:Outgoing Correspondence |
| TEAS EXTENSION RECEIVED | 2022-07-20 | 34 EEXT I:Incoming Correspondence |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2022-09-07 | 35 TROA I:Incoming Correspondence |
| ASSIGNED TO LIE | 2022-10-17 | 36 ALIE A:Allowance for Publication |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2022-10-17 | 37 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2022-10-17 | 38 TEME I:Incoming Correspondence |
| ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | 2022-10-19 | 39 CNPR P: |
| NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | 2022-10-20 | 40 SUNA E:E-Mail |
| ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED | 2022-10-21 | 41 ERRR O:Outgoing Correspondence |
| ELECTRONIC RECORD REVIEW COMPLETE | 2022-10-27 | 42 FIXD O:Outgoing Correspondence |
| NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | 2022-10-28 | 43 SUNA E:E-Mail |
| REGISTERED-PRINCIPAL REGISTER | 2022-11-29 | 44 R.PR A:Allowance for Publication |
| NOTICE OF REGISTRATION CONFIRMATION EMAILED | 2022-11-29 | 45 NRCC E:E-Mail |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 ILLUMINA COVIDSEQ 88983897 not registered Live/Pending |
Illumina, Inc. 2020-04-29 |
 ILLUMINA COVIDSEQ 88894074 not registered Live/Pending |
Illumina, Inc. 2020-04-29 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 